🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There is no effective standard treatment for fibrolamellar liver cancer tha...
Status
Completed
Location
University of California San Francisco
Start Date
2012-07-12
Trial ID
NCT01642186
Treatments Being Tested
To explore the efficacy and safety of chidamide combined with endocrine in ...
Status
Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-07-20
Trial ID
NCT05983107
Treatments Being Tested
This was an open-label, randomized controlled trial that aims to compare th...
Status
Completed
Location
Cancer Hospital/ Institute, Fudan University
Start Date
2013-05
Trial ID
NCT02980965
The purpose of this open-label, multicenter, phase IIIb, single-arm study i...
Status
Recruiting
Location
Central Alabama Research
Start Date
2024-02-28
Trial ID
NCT05827081
Treatments Being Tested
This is a Phase III, global, randomized, open-label, multicenter, study eva...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2021-08-27
Trial ID
NCT04961996
Treatments Being Tested
Eligible patients with estrogen receptor positive breast cancer will underg...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-11-13
Trial ID
NCT03573648
Treatments Being Tested
This is a phase 3, single arm, open-label study evaluating the effectivenes...
Status
Active Not Recruiting
Location
Marin Cancer Care, Inc
Start Date
2021-07-01
Trial ID
NCT04906395
Treatments Being Tested
To compare continuing bevacizumab + paclitaxel or switching to bevacizumab ...
Status
Completed
Location
Japan Breast Cancer Research Group
Start Date
2014-01
Trial ID
NCT01989780
Treatments Being Tested
TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the...
Status
Enrolling By Invitation
Location
Marin Cancer Care, Inc.
Start Date
2022-12-28
Trial ID
NCT05645536
Treatments Being Tested
Phase II, randomized, open-label, international, multicenter study to compa...
Status
Active Not Recruiting
Location
Complejo Hospitalario Universitario de Santiago (CHUS)
Start Date
2020-10-02
Trial ID
NCT04293393
Treatments Being Tested